{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T21:45:20Z","timestamp":1789854320601,"version":"4.0.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives de P\u00e9diatrie"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.arcped.2015.02.010","type":"journal-article","created":{"date-parts":[[2015,4,9]],"date-time":"2015-04-09T06:44:00Z","timestamp":1428561840000},"page":"536-539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Surdosage en carbamaz\u00e9pine par interaction avec les psychotropes\u00a0: \u00e0 propos de deux cas"],"prefix":"10.1016","volume":"22","author":[{"given":"A.","family":"Fernandez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Dor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-L.","family":"Menard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Askenazy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9993-6981","authenticated-orcid":false,"given":"S.","family":"Th\u00fcmmler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcped.2015.02.010_bib0005","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.2147\/NDT.S68951","article-title":"The safety and effectiveness of open-label extended-release carbamazepine in the treatment of children and adolescents with bipolar I disorder suffering from a manic or mixed episode","volume":"10","author":"Findling","year":"2014","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.arcped.2015.02.010_bib0010","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1474-4422(03)00409-5","article-title":"Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs","volume":"2","author":"Pastalos","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.arcped.2015.02.010_bib0015","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1124\/dmd.30.11.1170","article-title":"Pathways of carbamazepine bioactivation in vitro I. Characterization of human cytochromes P450\u00a0responsible for the formation of 2- and 3-hydroxylated metabolites","volume":"30","author":"Pearce","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.arcped.2015.02.010_bib0020","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/0006-2952(94)90071-X","article-title":"Human liver carbamazepine metabolism. Role of CYP3A4\u00a0and CYP2C8\u00a0in 10,11-epoxide formation","volume":"47","author":"Kerr","year":"1994","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.arcped.2015.02.010_bib0025","series-title":"Tableau \u00ab\u00a0Interactions m\u00e9dicamenteuses, cytochrome P450\u00a0et P-glycoproteine (Pgp)\u00a0\u00bb","author":"Service de pharmacologie et toxicologie clinique, H\u00f4pitaux Universitaires de Gen\u00e8ve","year":"2014"},{"key":"10.1016\/j.arcped.2015.02.010_bib0030","series-title":"Vidal 2014","year":"2014"},{"key":"10.1016\/j.arcped.2015.02.010_bib0035","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/clpt.1991.98","article-title":"Increased carbamazepine plasma concentrations after fluoxetine coadministration","volume":"50","author":"Grimsley","year":"1991","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.arcped.2015.02.010_bib0040","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.arcped.2009.06.012","article-title":"Utilisation hors autorisation de mise sur le march\u00e9 (AMM) des psychotropes en p\u00e9diatrie\u00a0: une \u00e9tude prospective","volume":"16","author":"Winterfeld","year":"2009","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.arcped.2015.02.010_bib0045","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0090-9556(24)15029-5","article-title":"Effect of antipsychotic drugs on human liver cytochrome P-450 (CYP) isoforms in vitro: preferential inhibition of CYP2D6","volume":"27","author":"Shin","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.arcped.2015.02.010_bib0050","doi-asserted-by":"crossref","first-page":"792456","DOI":"10.1155\/2013\/792456","article-title":"Comparative cytochrome p450\u00a0in vitro inhibition by atypical antipsychotic drugs","volume":"2013","author":"Gervasini","year":"2013","journal-title":"ISRN Pharmacol"},{"key":"10.1016\/j.arcped.2015.02.010_bib0055","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/00004714-200102000-00020","article-title":"Adverse drug interaction between risperidone and carbamazepine in a patient with chronic schizophrenia and deficient CYP2D6\u00a0activity","volume":"21","author":"Spina","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.arcped.2015.02.010_bib0060","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s00213-002-1056-8","article-title":"Significant pharmacokinetic interaction between risperidone and carbamazepine: its relationship with CYP2D6\u00a0genotypes","volume":"162","author":"Ono","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.arcped.2015.02.010_bib0065","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/01.pra.0000364285.55586.ad","article-title":"Antipsychotic prescribing practices following withdrawal of concomitant carbamazepine","volume":"15","author":"Strack","year":"2009","journal-title":"J Psychiatr Pract"},{"key":"10.1016\/j.arcped.2015.02.010_bib0070","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2174\/1389450043345263","article-title":"The role of cytochrome P450\u00a0enzymes in the metabolism of risperidone and its clinical relevance for drug interactions","volume":"5","author":"Berecz","year":"2004","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.arcped.2015.02.010_bib0075","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00002826-200203000-00007","article-title":"Carbamazepine-risperidone interactions in patients with epilepsy","volume":"25","author":"Mula","year":"2002","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.arcped.2015.02.010_bib0080","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1177\/106002809302701003","article-title":"Potential interaction between carbamazepine and loxapine: case report and retrospective review","volume":"27","author":"Collins","year":"1993","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.arcped.2015.02.010_bib0085","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/bdd.768","article-title":"In vitro identification of the human cytochrome p450\u00a0enzymes involved in the oxidative metabolism of loxapine","volume":"32","author":"Luo","year":"2011","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.arcped.2015.02.010_bib0090","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/clinchem\/44.5.1085","article-title":"Standards of laboratory practice: antiepileptic drug monitoring. National Academy of Clinical Biochemistry","volume":"44","author":"Warner","year":"1998","journal-title":"Clin Chem"},{"key":"10.1016\/j.arcped.2015.02.010_bib0095","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/clpt.2014.50","article-title":"Fluoxetine- and norfluoxetine-mediated complex drug-drug interactions: in vitro to in vivo correlation of effects on CYP2D6\u00a0CYP2C19, and CYP3A4","volume":"95","author":"Sager","year":"2014","journal-title":"Clin Pharmacol Ther"}],"container-title":["Archives de P\u00e9diatrie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X15000718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X15000718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T01:51:54Z","timestamp":1747878714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929693X15000718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0929693X15000718"],"URL":"https:\/\/doi.org\/10.1016\/j.arcped.2015.02.010","relation":{},"ISSN":["0929-693X"],"issn-type":[{"value":"0929-693X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surdosage en carbamaz\u00e9pine par interaction avec les psychotropes\u00a0: \u00e0 propos de deux cas","name":"articletitle","label":"Article Title"},{"value":"Archives de P\u00e9diatrie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcped.2015.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}